Tony Grover is a business development executive with over twenty years of experience focused on marketing, reimbursement, and commercial strategy for early stage companies.  He is the current Chairman of the BIOCOM Medical Device and Diagnostics Committee.  He served as Vice President of Business Development for Banyan Biomarkers, the first company to receive FDA approval for a blood test to diagnose mild TBI, or concussion.  Prior to Banyan Biomarkers he was the Director of Marketing and Reimbursement at PhotoThera, a privately held medical device company that raised over $100M for the treatment of ischemic stroke. Prior to joining PhotoThera, Mr. Grover was a management consultant for Pittiglio Rabin Todd & McGrath (PRTM), now PwC, where he worked with a variety of Fortune 500 companies to increase operational efficiency.  Mr. Grover is currently on the Advisory Board of the Global Brain Health Coalition that brings brain health awareness to patients, athletes, veterans, and caregivers. Mr. Grover previously served on the Board of Directors for the American Heart Association, San Diego from 2010-2012, as Chairman from 2012-2014, and as Past Chair in 2015.